Semaglutide in HFpEF and Obesity: Targeting Both for Functional Gains

Salvatore Carbone; Kershaw V. Patel

doi:10.1016/j.jchf.2025.102665

Semaglutide in HFpEF and Obesity: Targeting Both for Functional Gains

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	102665
Journal	JACC: Heart Failure
Volume	13
Issue number	11
DOIs	https://doi.org/10.1016/j.jchf.2025.102665
State	Published - Nov 2025

Keywords

6-minute walk test distance
heart failure with preserved ejection fraction
incretin
obesity

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jchf.2025.102665

Cite this

@article{30d55733e33a45a1b52bf1c48b145a9a,

title = "Semaglutide in HFpEF and Obesity: Targeting Both for Functional Gains",

keywords = "6-minute walk test distance, heart failure with preserved ejection fraction, incretin, obesity",

author = "Salvatore Carbone and Patel, \{Kershaw V.\}",

year = "2025",

month = nov,

doi = "10.1016/j.jchf.2025.102665",

language = "English (US)",

volume = "13",

journal = "JACC: Heart Failure",

issn = "2213-1779",

publisher = "Elsevier",

number = "11",

}

TY - JOUR

T1 - Semaglutide in HFpEF and Obesity

T2 - Targeting Both for Functional Gains

AU - Carbone, Salvatore

AU - Patel, Kershaw V.

PY - 2025/11

Y1 - 2025/11

KW - 6-minute walk test distance

KW - heart failure with preserved ejection fraction

KW - incretin

KW - obesity

UR - https://www.scopus.com/pages/publications/105016671971

UR - https://www.scopus.com/inward/citedby.url?scp=105016671971&partnerID=8YFLogxK

U2 - 10.1016/j.jchf.2025.102665

DO - 10.1016/j.jchf.2025.102665

M3 - Editorial

C2 - 40992091

AN - SCOPUS:105016671971

SN - 2213-1779

VL - 13

JO - JACC: Heart Failure

JF - JACC: Heart Failure

IS - 11

M1 - 102665

ER -

Semaglutide in HFpEF and Obesity: Targeting Both for Functional Gains

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this